CI
Cigna Corporation NYSE Listed Mar 31, 1982$284.06
Mkt Cap $75.1B
52w Low $239.51
44.8% of range
52w High $338.89
50d MA $274.50
200d MA $281.89
P/E (TTM)
12.7x
EV/EBITDA
8.4x
P/B
1.8x
Debt/Equity
0.8x
ROE
14.3%
P/FCF
8.7x
RSI (14)
—
ATR (14)
—
Beta
0.27
50d MA
$274.50
200d MA
$281.89
Avg Volume
1.7M
The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
900 Cottage Grove Road · Bloomfield, CT 06002 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | TNS | 7.60 | 7.79 | +2.5% | 290.58 | -0.5% | -2.6% | -3.9% | -5.1% | -3.0% | -2.3% | — |
| Feb 5, 2026 | TNS | 7.88 | 8.08 | +2.5% | 284.53 | -0.3% | +2.6% | +3.5% | +1.2% | +3.6% | +1.1% | — |
| Oct 30, 2025 | TNS | 7.64 | 7.83 | +2.5% | 247.10 | +0.4% | -1.1% | +4.7% | +7.1% | +5.1% | +3.8% | — |
| Jul 31, 2025 | TNS | 7.16 | 7.20 | +0.6% | 267.38 | +0.8% | -1.9% | -0.3% | +1.3% | +1.0% | +1.4% | — |
| May 2, 2025 | TNS | 6.35 | 6.74 | +6.1% | 334.75 | +0.7% | -0.5% | -0.3% | -0.1% | -0.5% | -0.4% | — |
| Jan 30, 2025 | TNS | 7.84 | 6.64 | -15.3% | 282.98 | +0.6% | +4.0% | +3.4% | +3.0% | +3.7% | +1.5% | — |
| Oct 31, 2024 | TNS | 7.23 | 7.51 | +3.9% | 314.81 | -0.5% | +0.5% | -0.8% | +1.1% | +0.1% | +1.5% | — |
| Aug 1, 2024 | TNS | 6.41 | 6.72 | +4.8% | 332.60 | +0.2% | +1.4% | -2.1% | -1.0% | -1.1% | +0.7% | — |
| May 2, 2024 | TNS | 6.22 | 6.47 | +4.0% | 344.50 | -0.6% | -0.9% | -0.6% | +0.6% | +0.8% | +1.9% | — |
| Feb 2, 2024 | TNS | 6.54 | 6.79 | +3.8% | 323.84 | +1.1% | -0.8% | +1.2% | +2.1% | +2.6% | +3.4% | — |
| Nov 2, 2023 | TNS | 6.66 | 6.77 | +1.7% | 318.89 | -0.4% | -2.6% | -3.8% | -7.5% | -7.4% | -9.4% | — |
| Aug 3, 2023 | TNS | 6.02 | 6.13 | +1.8% | 287.64 | +0.0% | -0.4% | +1.5% | +1.6% | +0.2% | +0.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Barclays | Maintains | Overweight → Overweight | — | $290.58 | $289.08 | -0.5% | -2.6% | -3.9% | -5.1% | -3.0% | -2.3% |
| May 1 | RBC Capital | Maintains | Outperform → Outperform | — | $290.58 | $289.08 | -0.5% | -2.6% | -3.9% | -5.1% | -3.0% | -2.3% |
| May 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $290.58 | $289.08 | -0.5% | -2.6% | -3.9% | -5.1% | -3.0% | -2.3% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $290.58 | $289.08 | -0.5% | -2.6% | -3.9% | -5.1% | -3.0% | -2.3% |
| Apr 20 | Jefferies | Maintains | Buy → Buy | — | $278.64 | $279.78 | +0.4% | +0.5% | -0.7% | -1.4% | +0.4% | -1.1% |
| Mar 12 | Bernstein | Upgrade | Market Perform → Outperform | — | $260.87 | $263.28 | +0.9% | +1.9% | +2.4% | +2.9% | +1.0% | +1.4% |
| Mar 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $290.85 | $283.00 | -2.7% | -2.4% | -2.1% | -3.3% | -6.6% | -7.3% |
| Feb 17 | Truist | Maintains | Buy → Buy | — | $291.44 | $294.43 | +1.0% | -0.3% | -0.5% | -1.9% | -3.8% | -2.8% |
| Feb 9 | TD Cowen | Maintains | Buy → Buy | — | $292.05 | $295.00 | +1.0% | +0.8% | -1.5% | +0.9% | -1.5% | -0.2% |
| Feb 6 | RBC Capital | Maintains | Outperform → Outperform | — | $284.53 | $283.72 | -0.3% | +2.6% | +3.5% | +1.2% | +3.6% | +1.1% |
| Feb 6 | Guggenheim | Maintains | Buy → Buy | — | $284.53 | $283.72 | -0.3% | +2.6% | +3.5% | +1.2% | +3.6% | +1.1% |
| Feb 6 | Barclays | Maintains | Overweight → Overweight | — | $284.53 | $283.72 | -0.3% | +2.6% | +3.5% | +1.2% | +3.6% | +1.1% |
| Feb 2 | Guggenheim | Maintains | Buy → Buy | — | $274.11 | $272.09 | -0.7% | -0.9% | +0.5% | -0.9% | +3.8% | +6.5% |
| Jan 5 | Barclays | Maintains | Overweight → Overweight | — | $279.12 | $277.62 | -0.5% | +1.7% | +2.0% | +0.0% | +1.7% | -0.1% |
| Jan 5 | Truist | Maintains | Buy → Buy | — | $279.12 | $277.62 | -0.5% | +1.7% | +2.0% | +0.0% | +1.7% | -0.1% |
| Nov 12 | Bernstein | Maintains | Market Perform → Market Perform | — | $268.00 | $266.50 | -0.6% | +1.0% | +1.1% | +0.6% | +1.2% | +1.7% |
| Nov 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $264.66 | $261.46 | -1.2% | -1.9% | -3.1% | -0.0% | -2.5% | +1.3% |
| Nov 4 | JP Morgan | Maintains | Overweight → Overweight | — | $258.62 | $257.70 | -0.4% | +2.3% | +0.4% | -0.9% | +2.3% | -0.2% |
| Nov 4 | Goldman Sachs | Maintains | Buy → Buy | — | $258.62 | $257.70 | -0.4% | +2.3% | +0.4% | -0.9% | +2.3% | -0.2% |
| Nov 4 | TD Cowen | Maintains | Buy → Buy | — | $258.62 | $257.70 | -0.4% | +2.3% | +0.4% | -0.9% | +2.3% | -0.2% |
| Nov 3 | Barclays | Maintains | Overweight → Overweight | — | $244.41 | $242.74 | -0.7% | +5.8% | +8.3% | +6.2% | +4.9% | +8.3% |
| Sep 4 | Barclays | Maintains | Overweight → Overweight | — | $300.48 | $299.26 | -0.4% | +1.2% | +1.6% | +0.1% | +0.5% | +0.7% |
| Aug 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $300.76 | $300.14 | -0.2% | -0.1% | -0.3% | -0.6% | +0.0% | -0.0% |
| Aug 14 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $287.10 | $281.36 | -2.0% | +1.1% | +3.4% | +3.9% | +5.2% | +6.1% |
| Aug 14 | Baird | Maintains | Outperform → Outperform | — | $287.10 | $281.36 | -2.0% | +1.1% | +3.4% | +3.9% | +5.2% | +6.1% |
| Aug 4 | Guggenheim | Maintains | Buy → Buy | — | $262.23 | $262.22 | -0.0% | +1.7% | +3.2% | +2.9% | +3.3% | +4.8% |
| Aug 1 | Barclays | Maintains | Overweight → Overweight | — | $267.38 | $269.49 | +0.8% | -1.9% | -0.3% | +1.3% | +1.0% | +1.4% |
| Jun 26 | RBC Capital | Maintains | Outperform → Outperform | — | $316.00 | $317.61 | +0.5% | +4.4% | +3.3% | +4.6% | +5.8% | +1.4% |
| Jun 3 | RBC Capital | Maintains | Outperform → Outperform | — | $314.99 | $312.31 | -0.9% | -1.1% | -1.5% | -1.3% | -0.9% | -1.1% |
| Jun 2 | Barclays | Maintains | Overweight → Overweight | — | $316.64 | $315.60 | -0.3% | -0.5% | -1.6% | -2.1% | -1.8% | -1.4% |
| May 23 | Guggenheim | Maintains | Buy → Buy | — | $312.68 | $314.20 | +0.5% | +1.1% | +0.8% | -0.6% | -0.2% | +1.3% |
| May 12 | Truist | Maintains | Buy → Buy | — | $333.46 | $324.08 | -2.8% | -5.3% | -9.5% | -9.0% | -7.4% | -3.8% |
| May 6 | Guggenheim | Maintains | Buy → Buy | — | $333.01 | $332.88 | -0.0% | +0.2% | +0.4% | +0.0% | +0.1% | -5.2% |
| May 5 | Guggenheim | Maintains | Buy → Buy | — | $334.75 | $337.01 | +0.7% | -0.5% | -0.3% | -0.1% | -0.5% | -0.4% |
| May 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $334.75 | $337.01 | +0.7% | -0.5% | -0.3% | -0.1% | -0.5% | -0.4% |
| May 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $334.75 | $337.01 | +0.7% | -0.5% | -0.3% | -0.1% | -0.5% | -0.4% |
| May 5 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $334.75 | $337.01 | +0.7% | -0.5% | -0.3% | -0.1% | -0.5% | -0.4% |
| May 5 | Barclays | Maintains | Overweight → Overweight | — | $334.75 | $337.01 | +0.7% | -0.5% | -0.3% | -0.1% | -0.5% | -0.4% |
| Apr 15 | Baird | Maintains | Outperform → Outperform | — | $329.20 | $329.97 | +0.2% | -0.2% | +0.1% | +0.3% | -1.3% | +2.4% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $327.27 | $323.73 | -1.1% | +0.9% | +0.6% | +0.4% | +0.7% | +0.9% |
| Apr 9 | Mizuho | Maintains | Outperform → Outperform | — | $313.84 | $311.79 | -0.7% | +2.0% | +4.3% | +5.2% | +4.9% | +4.7% |
| Mar 20 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $320.83 | $321.00 | +0.1% | +0.2% | -1.3% | -0.1% | -1.2% | +0.1% |
| Feb 4 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $292.46 | $289.32 | -1.1% | -0.3% | +0.3% | -1.8% | -2.0% | +0.1% |
| Feb 4 | Truist | Maintains | Buy → Buy | — | $292.46 | $289.32 | -1.1% | -0.3% | +0.3% | -1.8% | -2.0% | +0.1% |
| Feb 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $294.21 | $292.12 | -0.7% | -0.6% | -0.9% | -0.3% | -2.4% | -2.5% |
| Feb 3 | UBS | Maintains | Buy → Buy | — | $294.21 | $292.12 | -0.7% | -0.6% | -0.9% | -0.3% | -2.4% | -2.5% |
| Jan 31 | Stephens& Co. | Maintains | Overweight → Overweight | — | $282.98 | $284.71 | +0.6% | +4.0% | +3.4% | +3.0% | +3.7% | +1.5% |
| Jan 31 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $282.98 | $284.71 | +0.6% | +4.0% | +3.4% | +3.0% | +3.7% | +1.5% |
| Jan 31 | Barclays | Maintains | Overweight → Overweight | — | $282.98 | $284.71 | +0.6% | +4.0% | +3.4% | +3.0% | +3.7% | +1.5% |
| Jan 31 | RBC Capital | Maintains | Outperform → Outperform | — | $282.98 | $284.71 | +0.6% | +4.0% | +3.4% | +3.0% | +3.7% | +1.5% |
No insider trades available.
8-K
Cigna Corporation -- 8-K Filing
Cigna's leadership emphasizes strategic focus on healthcare innovation and digital transformation to enhance customer experience and operational efficiency across its insurance portfolio.
Apr 30
8-K
The Cigna Group -- 8-K Filing
Cigna Group shareholders will vote on an advisory measure regarding executive compensation practices, a non-binding referendum on management's pay structure.
Apr 27
8-K · 5.02
!!! Very High
The Cigna Group -- 8-K 5.02: Executive Change
Cigna Group appoints Brian C. Evanko as Chief Executive Officer effective July 1, 2026, signaling planned leadership transition and potential strategic direction change for the healthcare company.
Mar 3
8-K · 7.01
! Medium
The Cigna Group -- 8-K 7.01: Regulation FD Disclosure
Cigna Group reaffirmed its 2026 guidance of at least $30.25 adjusted earnings per share, signaling management confidence in achieving previously communicated financial targets.
Feb 27
8-K
The Cigna Group -- 8-K Filing
Cigna Group's 2025 initiatives focusing on expanded access, cost reduction, and transparency demonstrate management's commitment to improving customer value and operational efficiency.
Feb 5
Data updated apr 25, 2026 1:21am
· Source: massive.com